Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Antony Barbosa Institute (ABI) is a Brazilian center of excellence in aesthetic medicine and pharmaceutical research and development, founded by Dr. Antony de Paula Barbosa. The institute is recognized for pioneering the Body Harmonization (BHA) concept, which integrates advanced injectable techniques and pharmacotherapy for non-surgical body contouring and rejuvenation. ABI's research focuses on the efficacy and safety of collagen biostimulators, such as poly-L-lactic acid (PLLA) and calcium hydroxyapatite (CaHA), as well as the development of innovative protocols for facial and body aesthetics. Beyond clinical practice, the institute serves as a hub for professional training and scientific investigation into natural bioactive compounds and their applications in health and cosmetology. ABI also provides consultancy services to the pharmaceutical industry and contributes extensively to peer-reviewed literature in the fields of dermatology and pharmacology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antony de Paula Barbosa.